PM
Pamela G Marrone
Director

Pamela G Marrone insider trades: 180 Life Sciences (ATNF) stock buys and sales

Director, 180 Life Sciences Last trade May 18, 2023 48 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2014
2
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Pamela reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 18, 2023ATNF↑ Buy$8K
Jun 9, 2022MBII↓ Sell$24K
May 24, 2022MBII↓ Sell$24K
Mar 24, 2022MBII↓ Sell$25K
Dec 10, 2021ATNF↑ Buy$4K
Aug 24, 2021MBII↓ Sell$25K
Aug 9, 2021MBII↓ Sell$26K
Jul 26, 2021MBII↓ Sell$25K
Jul 9, 2021MBII↓ Sell$25K
Jun 24, 2021MBII↓ Sell$24K
Jun 9, 2021MBII↓ Sell$49K
Jun 9, 2016MBII↑ Buy$4K
Aug 12, 2014MBII↑ Buy$5K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Pamela G Marrone's insider trades

Pamela G Marrone is a director at 180 Life Sciences (ATNF). Since Aug 12, 2014, Pamela has reported 4 open-market purchases worth $20K and 9 sales worth $248K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (18 filings), option exercises (18 filings), shares returned to the company (1 filing), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ATNF insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.